We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other best ...
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
Teachers and staff facing potential job loss in West Bengal schools have returned to classrooms to ensure students' education isn't disrupted, despite the Supreme Court ruling. Many feel unjustly ...
“I’m just riding the government roller coaster,” says one worker, who lost her job in February, was placed on administrative leave in March, and plans to return to work later this month.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results